Strep Throat Clinical Trials

Find Strep Throat Clinical Trials Near You

A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF 3 LOTS OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS

Status: Recruiting
Location: See all (37) locations...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

The purpose of this study is to provide safety data and demonstrate lot consistency with the PG4 vaccine by evaluating the immunogenicity of 3 different lots of this vaccine. This study will compare a new pneumococcal vaccine with the vaccine currently in use to see if they are similarly safe. It will also compare three batches of the new vaccine to make sure they work the same way. Blood samples will be taken to measure how the body responds to the vaccines. The study will be conducted in the United States. Participants will be assigned to 1 of 4 groups. Group 1: PG4 vaccine lot 1; Group 2: PG4 vaccine lot 2; Group 3: PG4 vaccine lot 3; Group 4: 20vPnC. Within each group, participants will be assigned by chance in a 2:2:2:1 ratio to receive 1 vaccine injection (shot) with either PG4 (new vaccine) lot 1, PG4 lot 2, PG4 Lot 3 or 20vPnC, given in the arm. This means that for every 7 participants, about 2 will receive either PG4 lot 1, lot 2 or lot 3 and about 1 will receive 20vPnC. Each participant will take part in the study for approximately 6 months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 49
Healthy Volunteers: t
View:

• Adults 18 through 49 years of age, who have no history of receiving a pneumococcal vaccine after 5 years of age.

Locations
United States
Alabama
Achieve Clinical Research, LLC d/b/a Accel Research Sites - Birmingham Clinical Research Unit
RECRUITING
Birmingham
California
Orange County Research Center
RECRUITING
Lake Forest
Diablo Clinical Research, LLC dba Flourish Research
RECRUITING
Walnut Creek
Connecticut
Clinical Research Consulting
RECRUITING
Milford
Florida
Suncoast Research Associates
RECRUITING
Doral
Research Centers of America
RECRUITING
Hollywood
East Coast Institute for Research, LLC
RECRUITING
Jacksonville
Entrust Clinical Research
RECRUITING
Miami
Indago Research and Health Center, Inc.
RECRUITING
Miami Lakes
Palm Springs Community Health Center
RECRUITING
Miami Lakes
Innovation Medical Research, LLC
RECRUITING
Palmetto Bay
Palm Beach Research Center
RECRUITING
West Palm Beach
Georgia
Javara Inc.
RECRUITING
Fayetteville
Clinical Research Atlanta
RECRUITING
Stockbridge
Hawaii
East-West Medical Research Institute
RECRUITING
Honolulu
Iowa
Velocity Clinical Research, Sioux City
RECRUITING
Sioux City
Illinois
DM Clinical Research
RECRUITING
Melrose Park
Michigan
Henry Ford St. John Hospital - Thomas Mackey Center for Infectious Disease Research
RECRUITING
Grosse Pointe Woods
Missouri
Clinical Research Professionals
RECRUITING
Chesterfield
Bio-Kinetic Clinical Applications, LLC dba QPS-MO
RECRUITING
Springfield
Bio-Kinetic Clinical Applications, LLC dba QPS-MO-Screening and Recruitment Center
RECRUITING
Springfield
Sundance Clinical Research, LLC
RECRUITING
St Louis
North Carolina
Accellacare - Wilmington
RECRUITING
Wilmington
Nebraska
Velocity Clinical Research, Grand Island
RECRUITING
Grand Island
New Jersey
South Jersey Infectious Disease
RECRUITING
Somers Point
Ohio
Cincinnati Children's Hospital Medical Center Investigational Drug Services
RECRUITING
Cincinnati
Cincinnati Children's Hospital Medical Center Vaccine Research Center
RECRUITING
Cincinnati
CTI Clinical Research Center
RECRUITING
Cincinnati
Pennsylvania
DM Clinical Research
RECRUITING
Philadelphia
South Carolina
Clinical Trials of South Carolina
RECRUITING
Moncks Corner
TMA Headlands LLC (d/b/a Trial Management Associates)
RECRUITING
Myrtle Beach
Coastal Carolina Research Center, LLC
RECRUITING
North Charleston
Texas
SMS Clinical Research LLC
RECRUITING
Mesquite
DM Clinical Research - Sugar Land
RECRUITING
Sugar Land
DM Clinical Research
RECRUITING
Tomball
Utah
J. Lewis Research, Inc. / Foothill Family Clinic
RECRUITING
Salt Lake City
J. Lewis Research, Inc. / Foothill Family Clinic South
RECRUITING
Salt Lake City
Contact Information
Primary
Pfizer CT.gov Call Center
ClinicalTrials.gov_Inquiries@pfizer.com
1-800-718-1021
Time Frame
Start Date: 2026-09-08
Estimated Completion Date: 2027-06-07
Participants
Target number of participants: 4670
Treatments
Experimental: PG4 Vaccine Lot 3
Multivalent Pneumococcal Vaccine
Experimental: PG4 Vaccine Lot 2
Multivalent Pneumococcal Vaccine
Experimental: PG4 Vaccine Lot 1
Multivalent Pneumococcal Vaccine
Active_comparator: 20 Valent Pneumococcal Conjugate Vaccine (20vPnC)
20 Valent Pneumococcal Conjugate Vaccine
Related Therapeutic Areas
Sponsors
Leads: Pfizer

This content was sourced from clinicaltrials.gov